Transcriptional Fingerprinting meets Drug Discovery


Transcriptional Fingerprinting meets Drug Discovery


Transcriptional Fingerprinting meets Drug Discovery

Mission


 

QUANTRO will combine and exploit innovative technologies in the areas of functional-genetics and transcriptomics to generate an unprecedented cancer drug discovery pipeline transforming the precision and scope of cell-based compound screens.

Read more about the Company & Our Science.

 

October 14, 2025

QUANTRO Therapeutics extends collaboration with Boehringer Ingelheim to address high unmet needs in cancer patients

EN  | DE
 
Contact

Job Offers

QUANTRO Therapeutics GmbH
Dr. Bohr-Gasse 7
A-1030 Vienna, Austria

+43 122 66001

© 2023 QUANTRO Therapeutics GmbH